TMCI Treace Medical Concepts Inc

Price (delayed)

$8.05

Market cap

$499.17M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.88

Enterprise value

$559.08M

Based in Ponte Vedra, FL, Treace Medical Concepts, Inc. is a privately-held medical device company focused on advancing the standard of care for the surgical management of bunion deformities. The ...

Highlights
TMCI's revenue is up by 26% YoY and by 4.8% QoQ
Treace Medical Concepts's gross profit has increased by 25% YoY and by 4.5% from the previous quarter
Treace Medical Concepts's quick ratio has shrunk by 65% YoY and by 17% QoQ
The equity has declined by 20% year-on-year and by 8% since the previous quarter

Key stats

What are the main financial stats of TMCI
Market
Shares outstanding
62.01M
Market cap
$499.17M
Enterprise value
$559.08M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
3.93
Price to sales (P/S)
2.54
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.85
Earnings
Revenue
$196.03M
EBIT
-$49.55M
EBITDA
-$40.79M
Free cash flow
-$38.44M
Per share
EPS
-$0.88
Free cash flow per share
-$0.62
Book value per share
$2.05
Revenue per share
$3.17
TBVPS
$3.58
Balance sheet
Total assets
$242.73M
Total liabilities
$116.34M
Debt
$69.25M
Equity
$126.39M
Working capital
$140.35M
Liquidity
Debt to equity
0.55
Current ratio
3.98
Quick ratio
2.98
Net debt/EBITDA
-1.47
Margins
EBITDA margin
-20.8%
Gross margin
81%
Net margin
-27.9%
Operating margin
-28.9%
Efficiency
Return on assets
-22.2%
Return on equity
-39.7%
Return on invested capital
-20.3%
Return on capital employed
-25.3%
Return on sales
-25.3%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

TMCI stock price

How has the Treace Medical Concepts stock price performed over time
Intraday
1.26%
1 week
-4.73%
1 month
35.52%
1 year
-66.47%
YTD
-36.86%
QTD
21.05%

Financial performance

How have Treace Medical Concepts's revenue and profit performed over time
Revenue
$196.03M
Gross profit
$158.76M
Operating income
-$56.62M
Net income
-$54.75M
Gross margin
81%
Net margin
-27.9%
The operating income has contracted by 40% YoY and by 10% from the previous quarter
TMCI's revenue is up by 26% YoY and by 4.8% QoQ
Treace Medical Concepts's gross profit has increased by 25% YoY and by 4.5% from the previous quarter
The company's net income fell by 16% YoY and by 11% QoQ

Growth

What is Treace Medical Concepts's growth rate over time

Valuation

What is Treace Medical Concepts stock price valuation
P/E
N/A
P/B
3.93
P/S
2.54
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.85
The EPS has declined by 9% since the previous quarter and by 6% year-on-year
TMCI's P/B is 45% below its last 4 quarters average of 7.1
The equity has declined by 20% year-on-year and by 8% since the previous quarter
The P/S is 55% below the last 4 quarters average of 5.6
TMCI's revenue is up by 26% YoY and by 4.8% QoQ

Efficiency

How efficient is Treace Medical Concepts business performance
The return on equity has increased by 26% year-on-year but it has declined by 17% since the previous quarter
Treace Medical Concepts's return on invested capital has increased by 20% YoY but it has decreased by 15% QoQ
Treace Medical Concepts's ROA has increased by 15% YoY but it has decreased by 11% from the previous quarter
The return on sales is up by 8% year-on-year but it has declined by 7% since the previous quarter

Dividends

What is TMCI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for TMCI.

Financial health

How did Treace Medical Concepts financials performed over time
TMCI's total assets is 109% greater than its total liabilities
Treace Medical Concepts's quick ratio has shrunk by 65% YoY and by 17% QoQ
Treace Medical Concepts's current ratio has plunged by 58% YoY and by 10% from the previous quarter
TMCI's debt is 45% lower than its equity
The debt to equity has grown by 25% YoY and by 10% from the previous quarter
The equity has declined by 20% year-on-year and by 8% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.